Friday, June 18, 2021

Business

BioBiz: Amgen Inc received approval from The U.S. Food and Drug Administration for Lumakras

Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic...

Amazon signs agreement to Acquire MGM for $8.45 Billion

Amazon announced today that it will acquire the Metro Goldwyn Mayer’s (MGM) for $8.45 billion, significantly enhancing its online content strategy. “MGM has a vast catalog with more than 4,000 films—12 Angry Men, Basic...

Oatly stock soars nearly 30 percent during the company’s public market

Shares of the oat milk brand Oatly soared nearly 30 percent during the company’s public market debut Thursday. The stock began trading around 11:45 a.m. ET at $22.12, about 30 percent above the IPO price,...

BioBiz: Bristol Myers Squibb to Pay Up to $1.38 Billion to License Agenus’ Oncology Drug

Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38 billion. Under the licensing agreement, BMS will spearhead development and commercialization of...

Krispy Kreme flushed with new dough, files for IPO

Krispy Kreme said this week that it had confidentially filed with U.S. regulators for an initial public offering, a move that would result in the doughnut chain's return to the stock market five years after it was...

JAY-Z closes deal to sell TIDAL to Twitter co-founder Jack Dorsey

Jay-Z’s deal to sell his music-streaming service Tidal to Jack Dorsey’s financial services company Square has closed at more than $435 million. Square is paying $350 million for 80 percent of Tidal in the...

US economy surges in first quarter as COVID recovery gains steam

The US economy surged 6.4 percent in the first quarter of the year as the US recovery from the COVID-19 pandemic picked up speed, driven by government spending and mass vaccinations. America’s gross domestic...

Jessica Alba’s Honest Co. aims to go public and targets $1.5 billion valuation IPO

Celebrity brand, Honest Co. said Monday it was aiming for a valuation of over $1.5 billion in its initial public offering in the US. Actress Jessica Alba, known for her roles in film “Fantastic Four”...

Benzinga Makes an Investment in Crypto

The financial media company, Benzinga is diversifying its corporate treasury into Cryptocurrency, joining the innovative ranks of Tesla and MicroStrategy. Benzinga is among the nation's leading financial news outlets providing real-time news coverage to more brokerages than any...

BioBiz: Johnson & Johnson COVID-19 Vaccine stopped; Repertoire gets $189M infusion; Agenus presents clinical data; Solo-Dex launches and more

Both the FDA and Centers for Disease Control have decided to stop administering Johnson & Johnson’s Covid-19 vaccine after reviewing data involving six reported cases of a rare and severe type of blood clot in individuals in...
- Advertisement -

Latest News

“Can’t Cancel Pride” relief benefit special draws out big names in entertainment

Kylie Minogue, Leslie Odom Jr., Olly Alexander from Years & Years and Yola will join previously announced performers Bebe...
- Advertisement -

BioBiz: Amgen Inc received approval from The U.S. Food and Drug Administration for Lumakras

Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for...

Amazon signs agreement to Acquire MGM for $8.45 Billion

Amazon announced today that it will acquire the Metro Goldwyn Mayer’s (MGM) for $8.45 billion, significantly enhancing its online content strategy.

Oatly stock soars nearly 30 percent during the company’s public market

Shares of the oat milk brand Oatly soared nearly 30 percent during the company’s public market debut Thursday. The stock...

BioBiz: Bristol Myers Squibb to Pay Up to $1.38 Billion to License Agenus’ Oncology Drug

Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38...